ArticleAddiction science & clinical practice2021

Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial.

James S H Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.